4//SEC Filing
Roberts William T. 4
Accession 0001104659-23-019824
CIK 0001649904other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:02 PM ET
Size
9.2 KB
Accession
0001104659-23-019824
Insider Transaction Report
Form 4
Roberts William T.
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-09+2,313→ 7,253 total - Exercise/Conversion
Restricted Stock Units
2023-02-09−2,313→ 6,937 total→ Common Stock (2,313 underlying) - Sale
Common Stock
2023-02-09$27.66/sh−959$26,526→ 6,294 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]Includes 3,463 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022 and August 31, 2022.
- [F3]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001852360
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:02 PM ET
- Size
- 9.2 KB